Surgery Clinical Trial
— FIBRINOOfficial title:
Effects of Bariatric Surgery on obesity-and Diabetes-associated Abnormalities of Hemostasis, Inflammation and Vascular Function.
Verified date | October 2023 |
Source | Ersta Diakoni |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this prospective cohort study is to examine circulating biomarkers before and after weight loss in patients with obesity, with or without concomitant diabetes, undergoing bariatric surgery. The main questions that are being addressed are: - Do biomarkers of hemostasis, including coagulation, fibrinolysis, and platelet function improve following surgery and if so, is that improvement more pronounced in patients with diabetes? - Do biomarkers of endothelial function and other aspects of vascular function improve following surgery and if so, is that improvement more pronounced in patients with diabetes? - Do biomarkers of inflammation, including markers of adipocyte function, improve following surgery and if so, is that improvement more pronounced in patients with diabetes? - The possible role of circulating extracellular vesicles reflecting biological functions above will also be investigated (optional) Participants will be asked to attend in total five study visits before and after surgery including a final visit at two years post-surgery. Comparisons will be performed within- as well as between groups.
Status | Completed |
Enrollment | 61 |
Est. completion date | June 1, 2022 |
Est. primary completion date | December 31, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion criteria: - Age 18-70 years old - Planned for Roux-en-y gastric bypass surgery - Obesity fulfilling criteria for bariatric surgery (according to the European Association for the Study of Obesity guidelines, ref. Yumuk et al. European Guidelines for Obesity Management in Adults. Obes Facts 2015;8:402-42.) Exclusion criteria: - Ongoing treatment with anticoagulant medication - Ongoing treatment with antiplatelet medication other than acetylsalicylic acid - Type 1 diabetes |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Ersta Diakoni | Karolinska Institutet |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Blood tests for endothelial function comparing two years after surgery with baseline (below referred to as "changes in"). | Outcome measure:
Change in Hyaluronan (ng/ml) Change in Syndacan-1 (ng/ml) Change in E-selectin (ng/ml) Change in Thrombomodulin (pg/ml) Change in von Willebrand factor (%) |
before surgery - 2 years after surgery | |
Primary | Blood tests for fibrinolysis comparing two years after surgery with baseline (below referred to as "changes in"). | Outcome measure:
Change in PAI-1 activity (IU/ml) Change in Fibrinogen (pg/ml) Change in tPA activity (IU/ml) Change in PAP complex (ng/ml) Change in turbidimetric values - LagC (s) Change in turbidimetric values - LagL (s) Change in turbidimetric values - MaxAbsC (au) Change in turbidimetric values - MaxAbsL (au Change in turbidimetric values - Lys50MA (s) Change in turbidimetric values - CRC (au/s) Change in turbidimetric values - CRL (au/s) |
before surgery - 2 years after surgery | |
Primary | Blood tests for inflammation comparing two years after surgery with baseline (below referred to as "changes in"). | Outcome measure:
Change in high sensitivity CRP (microg/ml) Change in soluble IL6 receptor (ng/mL) Change in IL6 (pg/mL) Change in soluble gp130 (ng/mL) Change in TNFalfa (pg/ml) |
before surgery - 2 years after surgery | |
Primary | Blood tests for extracellular vesicles comparing two years after surgery with baseline (below referred to as "changes in"). | Exploratory analyses of extracellular vesicles (EV) in plasma using flow cytometry. EV exposing antigens of cell specific origin and/or biologically active molecules will be assessed. Outcome measure: Change in number of EVs (number of EV/micoL) | before surgery - 2 years after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT03213314 -
HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies
|
N/A | |
Enrolling by invitation |
NCT05534490 -
Surgery and Functionality in Older Adults
|
N/A | |
Recruiting |
NCT04792983 -
Cognition and the Immunology of Postoperative Outcomes
|
||
Terminated |
NCT04612491 -
Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery
|
||
Recruiting |
NCT06397287 -
PROM Project Urology
|
||
Recruiting |
NCT04444544 -
Quality of Life and High-Risk Abdominal Cancer Surgery
|
||
Completed |
NCT04204785 -
Noise in the OR at Induction: Patient and Anesthesiologists Perceptions
|
N/A | |
Completed |
NCT03432429 -
Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study
|
||
Completed |
NCT04176822 -
Designing Animated Movie for Preoperative Period
|
N/A | |
Recruiting |
NCT05370404 -
Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain:
|
N/A | |
Not yet recruiting |
NCT05467319 -
Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS
|
Phase 3 | |
Recruiting |
NCT04602429 -
Children's Acute Surgical Abdomen Programme
|
||
Completed |
NCT03124901 -
Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor
|
N/A | |
Completed |
NCT04595695 -
The Effect of Clear Masks in Improving Patient Relationships
|
N/A | |
Recruiting |
NCT06103136 -
Maestro 1.0 Post-Market Registry
|
||
Completed |
NCT05346588 -
THRIVE Feasibility Trial
|
Phase 3 | |
Completed |
NCT04059328 -
Novel Surgical Checklists for Gynecologic Laparoscopy in Haiti
|
||
Recruiting |
NCT03697278 -
Monitoring Postoperative Patient-controlled Analgesia (PCA)
|
N/A |